Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nkarta, Inc. Director's Dealing 2021

Apr 1, 2021

33926_dirs_2021-03-31_4b762a9a-dc39-49f3-9c68-13afec523f3b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Nkarta, Inc. (NKTX)
CIK: 0001787400
Period of Report: 2021-03-24

Reporting Person: Brandenberger Ralph (Sr. VP, Technical Operations)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $0.41 2028-07-18 Common Stock (8727) Direct
Stock Option (right to buy) $4.77 2029-05-10 Common Stock (10405) Direct
Stock Option (right to buy) $3.89 2029-09-05 Common Stock (52287) Direct
Stock Option (right to buy) $3.89 2029-09-05 Common Stock (34858) Direct
Stock Option (right to buy) $18.00 2030-07-08 Common Stock (18480) Direct
Stock Option (right to buy) $18.00 2030-07-08 Common Stock (17710) Direct
Stock Option (right to buy) $54.89 2031-01-07 Common Stock (30000) Direct

Footnotes

F1: The option is vested and exercisable as to 6,271 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on April 2, 2022.

F2: The option is vested and exercisable as to 5,675 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022.

F3: The option is vested and exercisable as to 18,334 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.

F4: The option is vested and exercisable as to 4,678 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024.

F5: The option is vested and exercisable as to 2,480 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024.

F6: The option is vested and exercisable as to 2,376 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on July 9, 2024.

F7: The option is vested and exercisable as to 1,250 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on January 8, 2025.